5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

C38H45N13O6 — CID 166008014

IUPAC5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESCn1cc(Nc2nc(N3CCN[C@@H](N4CCC5(CN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)C4=O)C3)cnc2C(N)=O)cn1
InChIInChI=1S/C38H45N13O6/c1-46-18-23(15-42-46)43-33-31(32(39)53)41-16-28(44-33)49-13-9-40-29(19-49)50-12-8-38(37(50)57)20-47(21-38)17-22-6-10-48(11-7-22)24-2-3-25-26(14-24)36(56)51(35(25)55)27-4-5-30(52)45-34(27)54/h2-3,14-16,18,22,27,29,40H,4-13,17,19-21H2,1H3,(H2,39,53)(H,43,44)(H,45,52,54)/t27?,29-/m0/s1
InChIKeyXZEPORUBHDAYKQ-ACEFPKFPSA-N
MW779.86 g/mol
LogP-0.36
Rot. Bonds9

About 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (PubChem CID 166008014) has the molecular formula C38H45N13O6 and a molecular weight of 779.86 g/mol. Its IUPAC name is 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.

Molecular Properties

Compound Name5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
PubChem CID166008014
Molecular FormulaC38H45N13O6
Molecular Weight779.86 g/mol
Exact Mass779.36
IUPAC Name5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESCn1cc(Nc2nc(N3CCN[C@@H](N4CCC5(CN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)C4=O)C3)cnc2C(N)=O)cn1
InChIInChI=1S/C38H45N13O6/c1-46-18-23(15-42-46)43-33-31(32(39)53)41-16-28(44-33)49-13-9-40-29(19-49)50-12-8-38(37(50)57)20-47(21-38)17-22-6-10-48(11-7-22)24-2-3-25-26(14-24)36(56)51(35(25)55)27-4-5-30(52)45-34(27)54/h2-3,14-16,18,22,27,29,40H,4-13,17,19-21H2,1H3,(H2,39,53)(H,43,44)(H,45,52,54)/t27?,29-/m0/s1
InChIKeyXZEPORUBHDAYKQ-ACEFPKFPSA-N
XLogP-0.36
TPSA224.33 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds9
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500779.86
LogP ≤ 5-0.36
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The IUPAC name of 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (CID 166008014) is 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.
What is the SMILES notation for 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The canonical SMILES for 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is Cn1cc(Nc2nc(N3CCN[C@@H](N4CCC5(CN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)C4=O)C3)cnc2C(N)=O)cn1.
What is the InChIKey of 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The InChIKey is XZEPORUBHDAYKQ-ACEFPKFPSA-N. The full InChI is InChI=1S/C38H45N13O6/c1-46-18-23(15-42-46)43-33-31(32(39)53)41-16-28(44-33)49-13-9-40-29(19-49)50-12-8-38(37(50)57)20-47(21-38)17-22-6-10-48(11-7-22)24-2-3-25-26(14-24)36(56)51(35(25)55)27-4-5-30(52)45-34(27)54/h2-3,14-16,18,22,27,29,40H,4-13,17,19-21H2,1H3,(H2,39,53)(H,43,44)(H,45,52,54)/t27?,29-/m0/s1.
What are the key properties of 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide has a molecular weight of 779.86 g/mol, XLogP of -0.36, 9 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3S)-3-[2-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-5-oxo-2,6-diazaspiro[3.4]octan-6-yl]piperazin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is sourced from PubChem (CID 166008014), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).